18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial.
Saved in:
| Title: | 18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial. |
|---|---|
| Authors: | van Geel JJL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands., Eisses B; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands., Elias SG; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Province Utrecht, The Netherlands., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Bensch F; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands., Gerritse SL; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Angus L; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kuip EJM; Department of Medical Oncology, Radboud Medical Center, Nijmegen, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Vugts DJ; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Emmering J; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Maasstad Hospital, Rotterdam, The Netherlands., Arens AIJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Oyen WJG; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Rijnstate, Arnhem, The Netherlands.; Department of Biomedical Sciences, Humanitas University and Department of Nuclear Medicine, Humanitas Clinical and Research Center, Milan, Italy., van der Vegt B; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Lub-de Hooge MN; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands., Menke-van der Houven van Oord CW; Department of Medical Oncology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Amsterdam, The Netherlands. |
| Corporate Authors: | IMPACT-Metastatic Breast Cancer Consortium |
| Source: | JAMA oncology [JAMA Oncol] 2026 Jun 01; Vol. 12 (6), pp. 611-618. |
| Publication Type: | Journal Article; Multicenter Study; Clinical Trial |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41989806 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22van+Geel+JJL%22">van Geel JJL</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Eisses+B%22">Eisses B</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Elias+SG%22">Elias SG</searchLink>; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Province Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Brouwers+AH%22">Brouwers AH</searchLink>; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bensch+F%22">Bensch F</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gerritse+SL%22">Gerritse SL</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Angus+L%22">Angus L</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Glaudemans+AWJM%22">Glaudemans AWJM</searchLink>; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kuip+EJM%22">Kuip EJM</searchLink>; Department of Medical Oncology, Radboud Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jager+A%22">Jager A</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Oprea-Lager+DE%22">Oprea-Lager DE</searchLink>; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vugts+DJ%22">Vugts DJ</searchLink>; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Emmering+J%22">Emmering J</searchLink>; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Maasstad Hospital, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Arens+AIJ%22">Arens AIJ</searchLink>; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Oyen+WJG%22">Oyen WJG</searchLink>; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Rijnstate, Arnhem, The Netherlands.; Department of Biomedical Sciences, Humanitas University and Department of Nuclear Medicine, Humanitas Clinical and Research Center, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22van+der+Vegt+B%22">van der Vegt B</searchLink>; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lub-de+Hooge+MN%22">Lub-de Hooge MN</searchLink>; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Menke-van+der+Houven+van+Oord+CW%22">Menke-van der Houven van Oord CW</searchLink>; Department of Medical Oncology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Vries+EGE%22">de Vries EGE</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Schröder+CP%22">Schröder CP</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Amsterdam, The Netherlands. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22IMPACT-Metastatic+Breast+Cancer+Consortium%22">IMPACT-Metastatic Breast Cancer Consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2026 Jun 01; Vol. 12 (6), pp. 611-618. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Clinical Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41989806 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamaoncol.2026.0767 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 611 Titles: – TitleFull: 18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: van Geel JJL – PersonEntity: Name: NameFull: Eisses B – PersonEntity: Name: NameFull: Elias SG – PersonEntity: Name: NameFull: Brouwers AH – PersonEntity: Name: NameFull: Bensch F – PersonEntity: Name: NameFull: Gerritse SL – PersonEntity: Name: NameFull: Angus L – PersonEntity: Name: NameFull: Glaudemans AWJM – PersonEntity: Name: NameFull: Kuip EJM – PersonEntity: Name: NameFull: Jager A – PersonEntity: Name: NameFull: Oprea-Lager DE – PersonEntity: Name: NameFull: Vugts DJ – PersonEntity: Name: NameFull: Emmering J – PersonEntity: Name: NameFull: Arens AIJ – PersonEntity: Name: NameFull: Oyen WJG – PersonEntity: Name: NameFull: van der Vegt B – PersonEntity: Name: NameFull: Lub-de Hooge MN – PersonEntity: Name: NameFull: Menke-van der Houven van Oord CW – PersonEntity: Name: NameFull: de Vries EGE – PersonEntity: Name: NameFull: Schröder CP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2374-2445 Numbering: – Type: volume Value: 12 – Type: issue Value: 6 Titles: – TitleFull: JAMA oncology Type: main |
| ResultId | 1 |
